Showing results (511-520 of 558) with videos related to
Sort By:
Pageof 56
European Urology Oncology|January 11, 2021
A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further ResearchAnthony S Bates, Jennifer Ayers, Nikolaos Kostakopoulos, et al.Intensive Care Medicine Experimental|June 29, 2025
29-mRNA host response signatures for classification of bacterial infection, viral infection and disease progression in COVID-19 pneumonia: a post hoc analysis of the SAVE-MORE randomized clinical trialEvdoxia Kyriazopoulou, Antigone Kotsaki, Asimina Safarika, et al.Critical Care (London, England)|March 13, 2024
Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trialEvdoxia Kyriazopoulou, Yehudit Hasin-Brumshtein, Uros Midic, et al.Cytokine|December 18, 2022
Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumoniaCharilaos Samaras, Evdoxia Kyriazopoulou, Garyfallia Poulakou, et al.Medicine|August 13, 2015
Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter StudyLorenzo Cavagna, Laura Nuño, Carlo Alberto Scirè, et al.Clinical Reviews in Allergy & Immunology|January 20, 2016
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative GroupLorenzo Cavagna, Laura Nuño, Carlo Alberto Scirè, et al.Eclinicalmedicine|January 2, 2023
Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trialKarolina Akinosoglou, Antigone Kotsaki, Ioanna-Maria Gounaridi, et al.European Urology|January 4, 2022
Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy StrategyPeter-Paul M Willemse, Niall F Davis, Nikolaos Grivas, et al.Arthritis & Rheumatology (Hoboken, N.J.)|April 11, 2020
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life SettingMariele Gatto, Francesca Saccon, Margherita Zen, et al.Journal of Personalized Medicine|April 28, 2023
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS)Margherita Zen, Mariele Gatto, Roberto Depascale, et al.Pageof 56